Gut bacteria-produced exopolysaccharides (EPS) help regulate metabolism by modulating gut microbiota, promoting SCFA ...
BioAge Labs, Inc. (BIOA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jeffrey ...
Analyst Samantha Semenkow from Citi maintained a Hold rating on BioAge Labs, Inc. (BIOA – Research Report) and keeping the price target at ...
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...
Recent research out of Cornell University showed that GLP-1 users' grocery bills have been reduced by as much as 8.6% — with ...
For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).
Discover the FDA-approved indications for GLP-1 receptors, including diabetes, weight loss, and cardiovascular disease. Learn brand-name and generic options.
If your genes could set an alarm clock, EZH1 might be the one ringing the bell. A new study has revealed how this ...
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
For the purpose of this guide, we looked at what 100 grams of protein looks like across different dietary styles -- vegan, vegetarian, omnivorous and carnivore. Four eggs (24 grams) One can of ...